Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

VaxEquity collaborates with AstraZeneca to progress saRNA platform technology

Sep. 23, 2021

AbCellera and Everest Medicines collaborate to discover therapeutic antibodies

Sep. 23, 2021

Rosalind Franklin University and Aptinyx collaborate on therapeutics for brain and CNS disorders

Sep. 23, 2021

OncoNano expands research collaboration with UTSW on novel cancer therapeutics

Sep. 23, 2021

Immunic signs license agreement for DHODH inhibitors and nucleoside analogues for viral infections

Sep. 23, 2021

Mosaic licenses rights to novel vaccine candidates from UC San Diego

Sep. 22, 2021

Theragnostics and AAA to jointly develop Ga-68 one-step PET radiopharmaceuticals

Sep. 22, 2021

CMTA and Addex collaborate to investigate GABA-B PAMs for CMT1A

Sep. 22, 2021

Clearmind and Hebrew University partner on novel psychedelics

Sep. 22, 2021

Trigone Pharma collaborates with 4C Biomed on intravesical immunotherapy for bladder cancer

Sep. 21, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...
ADCs, multispecific antibodies anchor $10B Pfizer-Innovent deal
BioWorld
Pfizer Inc. is paying Innovent Biologics Co. Ltd. $650 million up front and up to $9.85 billion in milestones, plus royalties, to collaborate across 12 early...